These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin. Liu Z; Larsen BT; Lerman LO; Gray BD; Barber C; Hedayat AF; Zhao M; Furenlid LR; Pak KY; Woolfenden JM Nucl Med Biol; 2016 Aug; 43(8):496-505. PubMed ID: 27236285 [TBL] [Abstract][Full Text] [Related]
44. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF. Hall MA; Pinkston KL; Wilganowski N; Robinson H; Ghosh P; Azhdarinia A; Vazquez-Arreguin K; Kolonin AM; Harvey BR; Sevick-Muraca EM J Nucl Med; 2012 Sep; 53(9):1427-37. PubMed ID: 22872743 [TBL] [Abstract][Full Text] [Related]
45. Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe. Ahmed M; Tegnebratt T; Tran TA; Lu L; Damberg P; Gisterå A; Tarnawski L; Bone D; Hedin U; Eriksson P; Holmin S; Gustafsson B; Caidahl K Int J Nanomedicine; 2020; 15():6137-6152. PubMed ID: 32884268 [TBL] [Abstract][Full Text] [Related]
46. Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer Hyafil F; Pelisek J; Laitinen I; Schottelius M; Mohring M; Döring Y; van der Vorst EP; Kallmayer M; Steiger K; Poschenrieder A; Notni J; Fischer J; Baumgartner C; Rischpler C; Nekolla SG; Weber C; Eckstein HH; Wester HJ; Schwaiger M J Nucl Med; 2017 Mar; 58(3):499-506. PubMed ID: 27789718 [No Abstract] [Full Text] [Related]
47. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Li D; Patel AR; Klibanov AL; Kramer CM; Ruiz M; Kang BY; Mehta JL; Beller GA; Glover DK; Meyer CH Circ Cardiovasc Imaging; 2010 Jul; 3(4):464-72. PubMed ID: 20442371 [TBL] [Abstract][Full Text] [Related]
48. Creager MD; Hohl T; Hutcheson JD; Moss AJ; Schlotter F; Blaser MC; Park MA; Lee LH; Singh SA; Alcaide-Corral CJ; Tavares AAS; Newby DE; Kijewski MF; Aikawa M; Di Carli M; Dweck MR; Aikawa E Circ Cardiovasc Imaging; 2019 Jan; 12(1):e007835. PubMed ID: 30642216 [TBL] [Abstract][Full Text] [Related]
49. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice. Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638 [TBL] [Abstract][Full Text] [Related]
50. PET/CT and MR imaging biomarker of lipid-rich plaques using [64Cu]-labeled scavenger receptor (CD68-Fc). Bigalke B; Phinikaridou A; Andia ME; Cooper MS; Schuster A; Wurster T; Onthank D; Münch G; Blower P; Gawaz M; Nagel E; Botnar RM Int J Cardiol; 2014 Nov; 177(1):287-91. PubMed ID: 25499394 [TBL] [Abstract][Full Text] [Related]
51. Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1. De Vos J; Mathijs I; Xavier C; Massa S; Wernery U; Bouwens L; Lahoutte T; Muyldermans S; Devoogdt N Mol Imaging Biol; 2014 Oct; 16(5):690-8. PubMed ID: 24687730 [TBL] [Abstract][Full Text] [Related]
52. Melanocortin overexpression limits diet-induced inflammation and atherosclerosis in LDLR Nuutinen S; Ailanen L; Savontaus E; Rinne P J Endocrinol; 2018 Mar; 236(3):111-123. PubMed ID: 29317531 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(-/-) mice. Li D; Liu Y; Zhang X; Lv H; Pang W; Sun X; Gan LM; Hammock BD; Ai D; Zhu Y J Mol Cell Cardiol; 2016 Sep; 98():128-37. PubMed ID: 27496380 [TBL] [Abstract][Full Text] [Related]